Topic
Pharmacological and technological innovations will lead to rapid improvements in medicinal products. Digitalisation, in particular, will bring about a fundamental change in the way medicines are developed and used, enabling new approaches to be adopted in research. These will create great potential for medical progress and benefits for patients. A concerted effort by all players is needed in order to implement this potential.
read more
Summer blog series together with the 3RCC Part 1: Bacterial Balance: Unravelling the Influence of Gut Microbiota on Zebrafish Social Behaviour
3 to our new Board members: Florian Schick President Merck Switzerland
3 questions to the new Interpharma Board members: Anne Mette Wiis Vogelsang, CVP & General Manager Novo Nordisk Switzerland
Rare diseases
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2023
read more
Introducing Interpharma
read more
More about the tasks and overriding aims of Interpharma
read more
Contact us
read more
Latest information and media contacts for media representatives
read more
read more
Download
Show all publications